GlassScriptPhysician profile
Sherman N Tran
NPI 1063407302
$2,775.01
in general payments reported to CMS, 2019-2025
8 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $210 · 2021: $354 · 2022: $713 · 2023: $470 · 2024: $540 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,849.47 | 2019-2025 | General - Dbs |
| Ibsa Pharma INC. | $272.36 | 2024 | Licart, Tirosint |
| Si-Bone, INC. | $251.26 | 2019-2022 | |
| Novo Nordisk INC | $106.06 | 2021 | |
| Depuy Synthes Sales INC. | $101.20 | 2025 | Fms Duo |
| Spr Therapeutics, INC | $94.83 | 2022 | |
| Medtronic, INC. | $84.55 | 2022 | |
| Vertiflex, INC. | $15.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherman Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.